CrushSCI.com
109.9平均天数
120中位天数
44最短天数
205最长天数
3912025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

153 天

Modeling ethnic differences via drug-predicted clearance from chemical structures

作者
Soyoka Tanihata; Akiko Watanabe; Koichi Handa; Hiroaki Iwata展开收起
作者单位
Department of Biological Regulation, Faculty of Medicine, Tottori University, Japan; Teijin Institute for Bio-medical Research, Teijin Pharma Limited, Japan; Pharmacokinetics Laboratory, Non-clinical Development Department, Research & Development Division, Meiji Seika Pharma, Co., Ltd, Japan展开收起
PDF源文件 DOI 网页
140 天

Evaluation of PRG4 mRNA-loaded polymeric nanoparticles in vitro and in vivo models of osteoarthritis

作者
Katrin Agnes Muenzebrock; Kelly Warmink; Remei Escudero Franch; Daniela M.J. Koster; Mattie Rijker; Yeter Dilek; Jie Du; Adriano P. Pontes; Niels Eijkelkamp; Joris Bekkers; Jaap Rip; Laura B. Creemers; Jaqueline Lourdes Rios展开收起
作者单位
Department of Orthopedics, University Medical Center Utrecht, Utrecht, the Netherlands; 20Med Therapeutics BV, Leiden, the Netherlands; Center for Translational Immunology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Orthopedics, Diakonessenhuis Hospital, Utrecht, the Netherlands展开收起
PDF源文件 DOI 网页
127 天

The impact of systemic redistribution on cutaneous pharmacokinetic-based bioequivalence: An in vivo dermal open flow microperfusion study for lidocaine and prilocaine

作者
Katrin I. Tiffner; Tannaz Ramezanli; Beate Boulgaropoulos; Thomas Birngruber; Manfred Bodenlenz; Bettina C. Lackner; Reingard Raml; Sam G. Raney; Frank Sinner展开收起
作者单位
Institute for Biomedical Research and Technologies (HEALTH), Joanneum Research Forschungsgesellschaft m.b.H, Neue Stiftingtalstrasse 2, Graz, 8010, Austria; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA; Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz, 8036, Austria展开收起
PDF源文件 DOI 网页
143 天

Discovery of a ROS-responsive dual-activity hydrogen sulfide donor against myocardial ischemia reperfusion injury

作者
Rong-Hong Zhang; Long-Fa Yang; Yi-Ying Lian; Jin-Feng Long; Hong-Fu Liu; Yong-Long Zhao; Shang-Gao Liao; Yong-Jun Li; Dan Yang; Meng Zhou展开收起
作者单位
State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), School of Pharmacy, Guizhou Medical University, Guian New District, Guizhou, 561113, PR China; Center for Tissue Engineering and Stem Cell Research, Key Laboratory of Regenerative Medicine of Guizhou Province, School of Basic Medical Sciences, Guizhou Medical University, Guian New District, Guizhou, 561113, PR China展开收起
PDF源文件 DOI 网页
69 天

Mechanistic characterization of norjuziphine–β-lactoglobulin nanocomplexes: Protein conformational remodeling governs encapsulation and therapeutic effects in human hepatocellular carcinoma cells

作者
Qing Cen; Wei Wang; Jie Pan; Haibo He; Weifeng Teng; Jingzhi Wang; Zhibin Bai展开收起
作者单位
Department of General Surgery, Cixi People's Hospital, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China; Pingyang Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325400, China; Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China; Department of Radiotherapy Oncology, The First People's Hospital of Yancheng, Yancheng No.1 People's Hospital, Affiliated Hospital of Medical School, Nanjing University, Yancheng, 224000, China展开收起
PDF源文件 DOI 网页
73 天

The top-down Finite Time Pharmacokinetic (FTPK) models vis-a-vis the bottom-up PBPK models in early drug development

作者
Panos Macheras; Nikos Alimpertis; Athanasios A. Tsekouras展开收起
作者单位
Faculty of Pharmacy, Laboratory of Biopharmaceutics Pharmacokinetics, National and Kapodistrian University of Athens, Athens, Greece; Finite Absorption Time (F.A.T.) Laboratories, National and Kapodistrian University of Athens, Athens, Greece; Department of Chemistry, Laboratory of Physical Chemistry, National and Kapodistrian University of Athens, Athens, Greece展开收起
PDF源文件 DOI 网页

FAQ

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES审稿要多久?

截至2026-11-13,CrushSCI 收录了 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 44 天(Synthesis and biological evaluation of 68Ga-DOTA-PLE: a Plectin-1-targeted radiotracer for PET/MR imaging of pancreatic cancer,2026-06-30 收稿,2026-08-13 录用),最慢一篇用了 205 天;平均 109.9 天,中位数 120 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。